| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 1.47e-05 | 100 | 62 | 5 | GO:0019888 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 2.66e-05 | 113 | 62 | 5 | GO:0019208 | |
| GeneOntologyMolecularFunction | retromer complex binding | 4.20e-04 | 10 | 62 | 2 | GO:1905394 | |
| GeneOntologyMolecularFunction | protein phosphatase inhibitor activity | 5.04e-04 | 50 | 62 | 3 | GO:0004864 | |
| GeneOntologyMolecularFunction | phosphatase inhibitor activity | 6.32e-04 | 54 | 62 | 3 | GO:0019212 | |
| GeneOntologyBiologicalProcess | mesenchyme migration | 2.58e-07 | 5 | 62 | 3 | GO:0090131 | |
| GeneOntologyBiologicalProcess | regulation of phosphatase activity | 2.86e-06 | 74 | 62 | 5 | GO:0010921 | |
| GeneOntologyBiologicalProcess | regulation of dephosphorylation | 4.15e-05 | 128 | 62 | 5 | GO:0035303 | |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 4.37e-05 | 65 | 62 | 4 | GO:0072132 | |
| GeneOntologyBiologicalProcess | protein dephosphorylation | 1.18e-04 | 256 | 62 | 6 | GO:0006470 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 1.48e-04 | 515 | 62 | 8 | GO:0022613 | |
| GeneOntologyBiologicalProcess | skeletal muscle thin filament assembly | 1.85e-04 | 7 | 62 | 2 | GO:0030240 | |
| HumanPheno | Disinhibition | MYT1L KMT2C FRMPD4 GLDC ASXL3 NSD1 ABCA7 CIC PUS7 LUZP1 HTT ZNF292 | 1.69e-05 | 807 | 21 | 12 | HP:0000734 |
| HumanPheno | Inappropriate behavior | MYT1L KMT2C FRMPD4 GLDC ASXL3 NSD1 ABCA7 CIC PUS7 LUZP1 HTT ZNF292 | 1.69e-05 | 807 | 21 | 12 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | MYT1L KMT2C FRMPD4 GLDC ASXL3 NSD1 ABCA7 CIC PUS7 LUZP1 HTT ZNF292 | 1.69e-05 | 807 | 21 | 12 | HP:5200123 |
| HumanPheno | Social disinhibition | MYT1L KMT2C FRMPD4 GLDC ASXL3 NSD1 ABCA7 CIC PUS7 LUZP1 HTT ZNF292 | 1.69e-05 | 807 | 21 | 12 | HP:5200029 |
| HumanPheno | Abnormally increased volition | MYT1L KMT2C FRMPD4 GLDC ASXL3 NSD1 ABCA7 CIC PUS7 LUZP1 HTT ZNF292 | 3.68e-05 | 869 | 21 | 12 | HP:5200263 |
| HumanPheno | Abnormal social development | MYT1L KMT2C FRMPD4 GLDC ASXL3 NSD1 ABCA7 CIC PUS7 LUZP1 HTT ZNF292 | 5.80e-05 | 908 | 21 | 12 | HP:0025732 |
| HumanPheno | Ventriculomegaly | MYT1L KMT2C ASXL3 ACTA2 NSD1 NUP188 ZBTB11 PUS7 LUZP1 HTT ZNF292 | 9.20e-05 | 790 | 21 | 11 | HP:0002119 |
| HumanPheno | Aggressive behavior | 1.01e-04 | 516 | 21 | 9 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 1.01e-04 | 516 | 21 | 9 | HP:0006919 | |
| HumanPheno | Reduced impulse control | MYT1L KMT2C FRMPD4 GLDC ASXL3 NSD1 ABCA7 CIC PUS7 LUZP1 HTT ZNF292 | 2.13e-04 | 1032 | 21 | 12 | HP:5200045 |
| HumanPheno | Tall stature | 2.16e-04 | 225 | 21 | 6 | HP:0000098 | |
| Domain | DUF4599 | 4.36e-08 | 12 | 59 | 4 | PF15371 | |
| Domain | DUF4599 | 4.36e-08 | 12 | 59 | 4 | IPR027970 | |
| Domain | ACTINS_1 | 1.66e-06 | 8 | 59 | 3 | PS00406 | |
| Domain | FAM21 | 9.81e-06 | 2 | 59 | 2 | IPR027308 | |
| Domain | ARM-type_fold | 1.07e-05 | 339 | 59 | 8 | IPR016024 | |
| Domain | Actin_CS | 1.63e-05 | 16 | 59 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 1.97e-05 | 17 | 59 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.36e-05 | 18 | 59 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 2.80e-05 | 19 | 59 | 3 | PS01132 | |
| Domain | FAM21/CAPZIP | 2.94e-05 | 3 | 59 | 2 | IPR029341 | |
| Domain | CAP-ZIP_m | 2.94e-05 | 3 | 59 | 2 | PF15255 | |
| Domain | Actin | 1.26e-04 | 31 | 59 | 3 | IPR004000 | |
| Domain | Actin | 1.26e-04 | 31 | 59 | 3 | PF00022 | |
| Domain | ACTIN | 1.26e-04 | 31 | 59 | 3 | SM00268 | |
| Domain | ZF_PHD_2 | 2.31e-04 | 95 | 59 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.40e-04 | 96 | 59 | 4 | PS01359 | |
| Domain | IMPORTIN_B_NT | 8.71e-04 | 14 | 59 | 2 | PS50166 | |
| Domain | IBN_N | 1.00e-03 | 15 | 59 | 2 | PF03810 | |
| Domain | Post-SET_dom | 1.14e-03 | 16 | 59 | 2 | IPR003616 | |
| Domain | PostSET | 1.14e-03 | 16 | 59 | 2 | SM00508 | |
| Domain | IBN_N | 1.14e-03 | 16 | 59 | 2 | SM00913 | |
| Domain | POST_SET | 1.14e-03 | 16 | 59 | 2 | PS50868 | |
| Domain | Importin-beta_N | 1.29e-03 | 17 | 59 | 2 | IPR001494 | |
| Domain | ARM-like | 1.61e-03 | 270 | 59 | 5 | IPR011989 | |
| Domain | PHD | 1.72e-03 | 75 | 59 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 2.00e-03 | 79 | 59 | 3 | IPR019787 | |
| Domain | PHD | 2.80e-03 | 89 | 59 | 3 | SM00249 | |
| Domain | Znf_PHD | 2.99e-03 | 91 | 59 | 3 | IPR001965 | |
| Domain | cEGF | 3.04e-03 | 26 | 59 | 2 | IPR026823 | |
| Domain | cEGF | 3.04e-03 | 26 | 59 | 2 | PF12662 | |
| Domain | Pkinase_C | 6.09e-03 | 37 | 59 | 2 | IPR017892 | |
| Domain | SET | 7.43e-03 | 41 | 59 | 2 | PF00856 | |
| Domain | Pkinase_C | 7.79e-03 | 42 | 59 | 2 | PF00433 | |
| Domain | SET | 9.29e-03 | 46 | 59 | 2 | SM00317 | |
| Pubmed | 9.93e-14 | 6 | 63 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 9.93e-14 | 6 | 63 | 5 | 25930072 | |
| Pubmed | 6.86e-10 | 24 | 63 | 5 | 32212159 | ||
| Pubmed | NOP58 URB1 TSR1 CEBPZ NSD1 NUP188 ZBTB11 DDX24 SNRNP200 PPP6R3 KPNB1 XPO7 | 1.93e-09 | 653 | 63 | 12 | 22586326 | |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 5.66e-09 | 3 | 63 | 3 | 7780165 | |
| Pubmed | Structural basis for regulation of protein phosphatase 1 by inhibitor-2. | 5.66e-09 | 3 | 63 | 3 | 17636256 | |
| Pubmed | Cloning and characterization of human phosphatase inhibitor-2 (IPP-2) sequences. | 2.26e-08 | 4 | 63 | 3 | 7949733 | |
| Pubmed | PPP1R2 PPP3CB SLC4A1AP TSR1 CEBPZ ACTA1 PPP1R13B LTBP1 CIC RCAN3 LUZP1 PPP6R3 KPNB1 | 4.11e-08 | 1049 | 63 | 13 | 27880917 | |
| Pubmed | KMT2C NOP58 CEBPZ NSD1 PPP1R13B SNRNP200 LUZP1 HTT PPP6R3 KPNB1 | 5.35e-08 | 549 | 63 | 10 | 38280479 | |
| Pubmed | 5.65e-08 | 5 | 63 | 3 | 30144392 | ||
| Pubmed | Protein Phosphatase-1 Inhibitor-2 Is a Novel Memory Suppressor. | 5.65e-08 | 5 | 63 | 3 | 26558779 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 1.13e-07 | 6 | 63 | 3 | 22989508 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 1.13e-07 | 6 | 63 | 3 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 1.13e-07 | 6 | 63 | 3 | 11709093 | |
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 1.13e-07 | 6 | 63 | 3 | 9971772 | |
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 10049817 | ||
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 1.13e-07 | 6 | 63 | 3 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 1.13e-07 | 6 | 63 | 3 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 1.13e-07 | 6 | 63 | 3 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 1.13e-07 | 6 | 63 | 3 | 8661406 | |
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 23017337 | ||
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 1.13e-07 | 6 | 63 | 3 | 10074138 | |
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 1.13e-07 | 6 | 63 | 3 | 23875777 | |
| Pubmed | 1.13e-07 | 6 | 63 | 3 | 9841925 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOP58 GNL3L RPS6KA4 FRMPD4 TSR1 CEBPZ ACTA1 ACTA2 ACTC1 SNRNP200 LUZP1 KPNB1 | 1.18e-07 | 949 | 63 | 12 | 36574265 |
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 1.97e-07 | 7 | 63 | 3 | 17504171 | |
| Pubmed | 1.97e-07 | 7 | 63 | 3 | 22535526 | ||
| Pubmed | 1.97e-07 | 7 | 63 | 3 | 22465675 | ||
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 1.97e-07 | 7 | 63 | 3 | 9384381 | |
| Pubmed | Inhibitor-2 prevents protein phosphatase 1-induced cardiac hypertrophy and mortality. | 1.97e-07 | 7 | 63 | 3 | 18689497 | |
| Pubmed | 1.97e-07 | 7 | 63 | 3 | 30289203 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 1.97e-07 | 7 | 63 | 3 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 1.97e-07 | 7 | 63 | 3 | 22640593 | |
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 14694110 | ||
| Pubmed | Primary cilia are WNT-transducing organelles whose biogenesis is controlled by a WNT-PP1 axis. | 3.15e-07 | 8 | 63 | 3 | 36693320 | |
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 20147394 | ||
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 23260110 | ||
| Pubmed | 3.15e-07 | 8 | 63 | 3 | 20096780 | ||
| Pubmed | 3.21e-07 | 506 | 63 | 9 | 30890647 | ||
| Pubmed | NOP58 URB1 GNL3L WASHC2C TSR1 CEBPZ GEMIN8 DDX24 SNRNP200 LUZP1 KPNB1 | 3.25e-07 | 847 | 63 | 11 | 35850772 | |
| Pubmed | Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. | 4.72e-07 | 9 | 63 | 3 | 12297046 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 4.72e-07 | 9 | 63 | 3 | 8892894 | |
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 4.72e-07 | 9 | 63 | 3 | 10556093 | |
| Pubmed | 4.72e-07 | 9 | 63 | 3 | 18775311 | ||
| Pubmed | Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. | 6.74e-07 | 10 | 63 | 3 | 21749862 | |
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 6.74e-07 | 10 | 63 | 3 | 1991513 | |
| Pubmed | 6.74e-07 | 10 | 63 | 3 | 23575248 | ||
| Pubmed | 6.74e-07 | 10 | 63 | 3 | 1907279 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PPP1R2B GNL3L WASHC2C ACTA1 ZNF622 SNRNP200 CIC PKN3 PUS7 PPP6R3 KPNB1 | 8.51e-07 | 934 | 63 | 11 | 33916271 |
| Pubmed | 9.25e-07 | 11 | 63 | 3 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 9.25e-07 | 11 | 63 | 3 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 9.25e-07 | 11 | 63 | 3 | 19639585 | |
| Pubmed | 9.25e-07 | 11 | 63 | 3 | 22207710 | ||
| Pubmed | 1.23e-06 | 12 | 63 | 3 | 23071112 | ||
| Pubmed | SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice. | 1.23e-06 | 12 | 63 | 3 | 31042497 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.47e-06 | 608 | 63 | 9 | 36089195 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOP58 URB1 GNL3L SLC4A1AP TSR1 CEBPZ ACTA1 ZBTB11 DDX24 SNRNP200 KPNB1 | 1.48e-06 | 989 | 63 | 11 | 36424410 |
| Pubmed | Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. | 1.60e-06 | 13 | 63 | 3 | 18400219 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PPP1R2 PPP3CB TSR1 ACTA1 ZNF622 NUP188 WASHC2A SNRNP200 PUS7 HTT PPP6R3 KPNB1 XPO7 | 1.69e-06 | 1455 | 63 | 13 | 22863883 |
| Pubmed | 2.03e-06 | 14 | 63 | 3 | 21923909 | ||
| Pubmed | 2.03e-06 | 14 | 63 | 3 | 17411366 | ||
| Pubmed | 2.54e-06 | 15 | 63 | 3 | 24598388 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 2.71e-06 | 486 | 63 | 8 | 30940648 | |
| Pubmed | Extraocular muscle morphogenesis and gene expression are regulated by Pitx2 gene dose. | 3.12e-06 | 16 | 63 | 3 | 16638982 | |
| Pubmed | Serum response factor is essential for mesoderm formation during mouse embryogenesis. | 3.12e-06 | 16 | 63 | 3 | 9799237 | |
| Pubmed | Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. | 3.23e-06 | 2 | 63 | 2 | 19468071 | |
| Pubmed | Identification and characterization of two distinct PPP1R2 isoforms in human spermatozoa. | 3.23e-06 | 2 | 63 | 2 | 23506001 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 20706863 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 15847701 | ||
| Pubmed | alpha-Actin proteins and gene transcripts are colocalized in embryonic mouse muscle. | 3.23e-06 | 2 | 63 | 2 | 1893870 | |
| Pubmed | Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer. | 3.23e-06 | 2 | 63 | 2 | 26927700 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 3023046 | ||
| Pubmed | Inhibition of the calcineurin-NFAT signalling cascade in the treatment of heart failure. | 3.23e-06 | 2 | 63 | 2 | 19925438 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 20827171 | ||
| Pubmed | Muscle specific expression of Cre recombinase under two actin promoters in transgenic mice. | 3.23e-06 | 2 | 63 | 2 | 10686609 | |
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 3.23e-06 | 2 | 63 | 2 | 36717248 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 3075543 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 2731651 | ||
| Pubmed | A fetal skeletal muscle actin mRNA in the mouse and its identity with cardiac actin mRNA. | 3.23e-06 | 2 | 63 | 2 | 6897014 | |
| Pubmed | 3.78e-06 | 17 | 63 | 3 | 17360745 | ||
| Pubmed | 3.78e-06 | 17 | 63 | 3 | 8997639 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KMT2C URB1 NSD1 NUP188 ZNF236 WASHC2A ABCA7 CIC PKN3 HTT BAHCC1 | 4.30e-06 | 1105 | 63 | 11 | 35748872 |
| Pubmed | 4.53e-06 | 18 | 63 | 3 | 24840128 | ||
| Pubmed | 4.53e-06 | 18 | 63 | 3 | 15929941 | ||
| Pubmed | 5.38e-06 | 19 | 63 | 3 | 30700554 | ||
| Pubmed | Heart-specific ablation of Prkar1a causes failure of heart development and myxomagenesis. | 5.38e-06 | 19 | 63 | 3 | 18316483 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 6.06e-06 | 724 | 63 | 9 | 36232890 | |
| Pubmed | Protein phosphatase 1α interacting proteins in the human brain. | 6.88e-06 | 67 | 63 | 4 | 22321011 | |
| Pubmed | 7.36e-06 | 21 | 63 | 3 | 20230754 | ||
| Pubmed | Myocardial Mycn is essential for mouse ventricular wall morphogenesis. | 7.36e-06 | 21 | 63 | 3 | 23063798 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 7.77e-06 | 398 | 63 | 7 | 35016035 | |
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 8.51e-06 | 22 | 63 | 3 | 16526095 | |
| Pubmed | NOP58 URB1 GNL3L TMEM183A CEBPZ ACTA2 ZNF622 NUP188 DDX24 SNRNP200 PPP6R3 KPNB1 | 9.13e-06 | 1440 | 63 | 12 | 30833792 | |
| Pubmed | NOP58 TSR1 CEBPZ ACTC1 ZNF622 ZBTB11 DDX24 SNRNP200 PPP6R3 KPNB1 | 9.19e-06 | 971 | 63 | 10 | 33306668 | |
| Pubmed | Bmp2 regulates the interaction between EPDCs and myocytes in cardiac OFT. | 9.68e-06 | 3 | 63 | 2 | 22647617 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 22855565 | ||
| Pubmed | Actin and myosin genes are transcriptionally regulated during mouse skeletal muscle development. | 9.68e-06 | 3 | 63 | 2 | 1728592 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 24195737 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 12119014 | ||
| Interaction | ZNF330 interactions | NOP58 URB1 GNL3L SLC4A1AP TSR1 CEBPZ NSD1 ZNF622 NUP188 ZBTB11 DDX24 PUS7 ZNF292 XPO7 | 4.81e-11 | 446 | 61 | 14 | int:ZNF330 |
| Interaction | POLR1G interactions | NOP58 URB1 GNL3L SLC4A1AP TSR1 CEBPZ NSD1 NUP188 ZBTB11 DDX24 CIC ZNF292 XPO7 | 1.96e-09 | 489 | 61 | 13 | int:POLR1G |
| Interaction | SIRT7 interactions | NOP58 URB1 TSR1 CEBPZ NSD1 NUP188 ZBTB11 DDX24 SNRNP200 PPP6R3 KPNB1 XPO7 | 1.94e-06 | 744 | 61 | 12 | int:SIRT7 |
| Interaction | KPNB1 interactions | 4.95e-06 | 544 | 61 | 10 | int:KPNB1 | |
| Interaction | COIL interactions | NOP58 URB1 CEBPZ NSD1 NUP188 ZBTB11 DDX24 SNRNP200 ZNF292 XPO7 | 5.63e-06 | 552 | 61 | 10 | int:COIL |
| Interaction | RPL23AP32 interactions | 6.57e-06 | 87 | 61 | 5 | int:RPL23AP32 | |
| Interaction | RAE1 interactions | 7.04e-06 | 236 | 61 | 7 | int:RAE1 | |
| Interaction | DHX40 interactions | 9.98e-06 | 249 | 61 | 7 | int:DHX40 | |
| Interaction | RPS6 interactions | NOP58 URB1 GNL3L TSR1 CEBPZ PPP1R13B NUP188 ZBTB11 DDX24 CIC HTT KPNB1 | 1.01e-05 | 874 | 61 | 12 | int:RPS6 |
| Interaction | POLR1E interactions | 1.01e-05 | 350 | 61 | 8 | int:POLR1E | |
| Interaction | HNRNPU interactions | NOP58 GNL3L TSR1 CEBPZ GLDC ASXL3 ZNF622 USP4 DDX24 SNRNP200 CIC PKN3 KPNB1 | 1.06e-05 | 1035 | 61 | 13 | int:HNRNPU |
| Interaction | WASHC4 interactions | 1.43e-05 | 102 | 61 | 5 | int:WASHC4 | |
| Interaction | ING1 interactions | 1.50e-05 | 103 | 61 | 5 | int:ING1 | |
| Interaction | NUP43 interactions | NOP58 GNL3L CEBPZ NSD1 ACTC1 ZBTB11 DDX24 SNRNP200 ZNF292 KPNB1 | 1.66e-05 | 625 | 61 | 10 | int:NUP43 |
| Interaction | REG3A interactions | 1.74e-05 | 17 | 61 | 3 | int:REG3A | |
| Interaction | POTEJ interactions | 1.84e-05 | 52 | 61 | 4 | int:POTEJ | |
| Interaction | BRD7 interactions | NOP58 GNL3L TSR1 ACTA1 ACTA2 ACTC1 DDX24 SNRNP200 PKN3 KPNB1 | 1.95e-05 | 637 | 61 | 10 | int:BRD7 |
| Interaction | LARP7 interactions | NOP58 GNL3L TSR1 CEBPZ GLDC ACTA1 ACTA2 NSD1 ACTC1 USP4 ZBTB11 DDX24 KPNB1 | 2.28e-05 | 1113 | 61 | 13 | int:LARP7 |
| Interaction | RPS24 interactions | 2.85e-05 | 529 | 61 | 9 | int:RPS24 | |
| Interaction | NMD3 interactions | 3.14e-05 | 120 | 61 | 5 | int:NMD3 | |
| Interaction | HAPSTR1 interactions | URB1 SLC4A1AP TSR1 FSIP1 ASXL3 ACTC1 DGKG USP4 NUP188 PPP6R3 KPNB1 | 3.40e-05 | 829 | 61 | 11 | int:HAPSTR1 |
| Interaction | GC interactions | 3.72e-05 | 62 | 61 | 4 | int:GC | |
| Interaction | FZR1 interactions | GPRASP1 RNF7 NOP58 GNL3L TSR1 CEBPZ ACTC1 ZNF622 ZBTB11 DDX24 SNRNP200 PPP6R3 KPNB1 | 3.91e-05 | 1172 | 61 | 13 | int:FZR1 |
| Interaction | DYRK1A interactions | 3.97e-05 | 552 | 61 | 9 | int:DYRK1A | |
| Interaction | ACTC1 interactions | SLC4A1AP ACTA1 ACTA2 ACTC1 WASHC2A SNRNP200 CIC PUS7 LUZP1 KPNB1 | 4.05e-05 | 694 | 61 | 10 | int:ACTC1 |
| Interaction | LIMA1 interactions | 4.33e-05 | 429 | 61 | 8 | int:LIMA1 | |
| Interaction | NIFK interactions | 4.48e-05 | 431 | 61 | 8 | int:NIFK | |
| Interaction | NUP153 interactions | 4.80e-05 | 216 | 61 | 6 | int:NUP153 | |
| Interaction | MEN1 interactions | KMT2C NOP58 URB1 GNL3L WASHC2C TSR1 CEBPZ GEMIN8 NUP188 DDX24 SNRNP200 LUZP1 | 5.04e-05 | 1029 | 61 | 12 | int:MEN1 |
| Interaction | NOP56 interactions | 5.09e-05 | 570 | 61 | 9 | int:NOP56 | |
| Interaction | RUVBL1 interactions | 5.44e-05 | 575 | 61 | 9 | int:RUVBL1 | |
| Interaction | NOP14 interactions | 5.59e-05 | 222 | 61 | 6 | int:NOP14 | |
| Interaction | DUSP10 interactions | 6.34e-05 | 71 | 61 | 4 | int:DUSP10 | |
| Interaction | PPP1CB interactions | 8.09e-05 | 469 | 61 | 8 | int:PPP1CB | |
| Interaction | TNNI3 interactions | 8.19e-05 | 28 | 61 | 3 | int:TNNI3 | |
| Interaction | RPL4 interactions | 9.05e-05 | 764 | 61 | 10 | int:RPL4 | |
| Interaction | TMSB4X interactions | 1.01e-04 | 80 | 61 | 4 | int:TMSB4X | |
| Interaction | ADARB1 interactions | 1.08e-04 | 489 | 61 | 8 | int:ADARB1 | |
| Interaction | PPP1R11 interactions | 1.12e-04 | 31 | 61 | 3 | int:PPP1R11 | |
| Interaction | CAPZA1 interactions | 1.16e-04 | 366 | 61 | 7 | int:CAPZA1 | |
| Interaction | SPTAN1 interactions | 1.19e-04 | 496 | 61 | 8 | int:SPTAN1 | |
| Interaction | NOPCHAP1 interactions | 1.23e-04 | 32 | 61 | 3 | int:NOPCHAP1 | |
| Interaction | DHX15 interactions | 1.30e-04 | 502 | 61 | 8 | int:DHX15 | |
| Interaction | CENPA interactions | 1.39e-04 | 377 | 61 | 7 | int:CENPA | |
| Interaction | DOT1L interactions | NOP58 URB1 GNL3L TSR1 CEBPZ GEMIN8 DDX24 SNRNP200 LUZP1 KPNB1 | 1.42e-04 | 807 | 61 | 10 | int:DOT1L |
| Interaction | H1-4 interactions | 1.48e-04 | 656 | 61 | 9 | int:H1-4 | |
| Interaction | NAA40 interactions | PPP1R2B GNL3L WASHC2C ACTA1 ZNF622 SNRNP200 CIC PKN3 PUS7 PPP6R3 KPNB1 | 1.49e-04 | 978 | 61 | 11 | int:NAA40 |
| Interaction | PHAX interactions | 1.50e-04 | 167 | 61 | 5 | int:PHAX | |
| Interaction | RPLP0 interactions | 1.55e-04 | 660 | 61 | 9 | int:RPLP0 | |
| Interaction | WASHC5 interactions | 1.60e-04 | 90 | 61 | 4 | int:WASHC5 | |
| Interaction | H1-2 interactions | 1.66e-04 | 666 | 61 | 9 | int:H1-2 | |
| Interaction | ALB interactions | 1.74e-04 | 391 | 61 | 7 | int:ALB | |
| Interaction | GNL1 interactions | 1.74e-04 | 92 | 61 | 4 | int:GNL1 | |
| Interaction | ABRA interactions | 1.75e-04 | 36 | 61 | 3 | int:ABRA | |
| Interaction | DNASE1 interactions | 1.87e-04 | 7 | 61 | 2 | int:DNASE1 | |
| Interaction | WASHC1 interactions | 1.89e-04 | 94 | 61 | 4 | int:WASHC1 | |
| Interaction | RPL31 interactions | 1.94e-04 | 680 | 61 | 9 | int:RPL31 | |
| Interaction | ZNF467 interactions | 2.08e-04 | 179 | 61 | 5 | int:ZNF467 | |
| Interaction | PFKP interactions | 2.15e-04 | 284 | 61 | 6 | int:PFKP | |
| Interaction | PPP3CB interactions | 2.22e-04 | 98 | 61 | 4 | int:PPP3CB | |
| Interaction | PPP1CA interactions | 2.31e-04 | 696 | 61 | 9 | int:PPP1CA | |
| Interaction | RPL10 interactions | 2.46e-04 | 702 | 61 | 9 | int:RPL10 | |
| Interaction | TNIP1 interactions | NOP58 GNL3L RPS6KA4 FRMPD4 TSR1 CEBPZ ACTA1 ACTA2 ACTC1 SNRNP200 LUZP1 KPNB1 | 2.46e-04 | 1217 | 61 | 12 | int:TNIP1 |
| Interaction | TERF2IP interactions | 2.47e-04 | 552 | 61 | 8 | int:TERF2IP | |
| Interaction | WWTR1 interactions | 2.77e-04 | 422 | 61 | 7 | int:WWTR1 | |
| Interaction | ZNF692 interactions | 2.78e-04 | 42 | 61 | 3 | int:ZNF692 | |
| Interaction | DDX21 interactions | 2.90e-04 | 718 | 61 | 9 | int:DDX21 | |
| Interaction | FASN interactions | KMT2C GLDC ASXL3 ACTC1 ZNF622 USP4 LTBP1 NUP188 ZNF236 HTT ZNF292 | 3.05e-04 | 1062 | 61 | 11 | int:FASN |
| Interaction | PLEC interactions | 3.10e-04 | 430 | 61 | 7 | int:PLEC | |
| Interaction | CAPZA2 interactions | 3.10e-04 | 430 | 61 | 7 | int:CAPZA2 | |
| Interaction | ERRFI1 interactions | 3.11e-04 | 107 | 61 | 4 | int:ERRFI1 | |
| Interaction | H2AB2 interactions | 3.11e-04 | 107 | 61 | 4 | int:H2AB2 | |
| Interaction | PPP1R7 interactions | 3.57e-04 | 111 | 61 | 4 | int:PPP1R7 | |
| Interaction | ADISSP interactions | 3.65e-04 | 46 | 61 | 3 | int:ADISSP | |
| Interaction | ANGPTL8 interactions | 3.99e-04 | 10 | 61 | 2 | int:ANGPTL8 | |
| Interaction | PFN3 interactions | 3.99e-04 | 10 | 61 | 2 | int:PFN3 | |
| Interaction | ZBTB2 interactions | 4.07e-04 | 450 | 61 | 7 | int:ZBTB2 | |
| Interaction | CHD3 interactions | 4.28e-04 | 757 | 61 | 9 | int:CHD3 | |
| Interaction | ACTG2 interactions | 4.40e-04 | 49 | 61 | 3 | int:ACTG2 | |
| Interaction | NOLC1 interactions | 4.42e-04 | 325 | 61 | 6 | int:NOLC1 | |
| Interaction | GSN interactions | 4.53e-04 | 212 | 61 | 5 | int:GSN | |
| Interaction | ZMAT2 interactions | 4.65e-04 | 119 | 61 | 4 | int:ZMAT2 | |
| Interaction | WASH8P interactions | 4.87e-04 | 11 | 61 | 2 | int:WASH8P | |
| Interaction | GSK3A interactions | 4.89e-04 | 464 | 61 | 7 | int:GSK3A | |
| Interaction | WASHC2A interactions | 5.11e-04 | 122 | 61 | 4 | int:WASHC2A | |
| Interaction | CSNK2A1 interactions | 5.49e-04 | 956 | 61 | 10 | int:CSNK2A1 | |
| Interaction | HSP90AB1 interactions | 5.67e-04 | 960 | 61 | 10 | int:HSP90AB1 | |
| Interaction | RSL1D1 interactions | 5.91e-04 | 479 | 61 | 7 | int:RSL1D1 | |
| Interaction | HNRNPC interactions | 6.22e-04 | 634 | 61 | 8 | int:HNRNPC | |
| Interaction | SNRNP40 interactions | 6.41e-04 | 637 | 61 | 8 | int:SNRNP40 | |
| Interaction | FBL interactions | 6.54e-04 | 639 | 61 | 8 | int:FBL | |
| Interaction | GAR1 interactions | 6.82e-04 | 232 | 61 | 5 | int:GAR1 | |
| Interaction | BUB3 interactions | 6.82e-04 | 232 | 61 | 5 | int:BUB3 | |
| Interaction | PPP1R1A interactions | 6.88e-04 | 13 | 61 | 2 | int:PPP1R1A | |
| Interaction | PCYT1B interactions | 6.88e-04 | 13 | 61 | 2 | int:PCYT1B | |
| Interaction | SNORD3A interactions | 6.88e-04 | 13 | 61 | 2 | int:SNORD3A | |
| Interaction | SUZ12 interactions | 6.88e-04 | 644 | 61 | 8 | int:SUZ12 | |
| Interaction | H3C3 interactions | 7.17e-04 | 495 | 61 | 7 | int:H3C3 | |
| Interaction | SCIN interactions | 7.23e-04 | 58 | 61 | 3 | int:SCIN | |
| Interaction | MAGEA3 interactions | 7.27e-04 | 134 | 61 | 4 | int:MAGEA3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 5.16e-05 | 8 | 63 | 2 | chr9q12 | |
| Cytoband | 9p13.1 | 5.02e-04 | 24 | 63 | 2 | 9p13.1 | |
| Cytoband | Xp22.2 | 1.40e-03 | 40 | 63 | 2 | Xp22.2 | |
| Cytoband | 15q14 | 2.09e-03 | 49 | 63 | 2 | 15q14 | |
| Cytoband | 9q34.11 | 2.44e-03 | 53 | 63 | 2 | 9q34.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q14 | 3.22e-03 | 61 | 63 | 2 | chr15q14 | |
| GeneFamily | Actins | 1.85e-07 | 6 | 39 | 3 | 929 | |
| GeneFamily | WASH complex | 6.76e-05 | 6 | 39 | 2 | 1331 | |
| GeneFamily | PHD finger proteins | 9.58e-04 | 90 | 39 | 3 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.44e-03 | 34 | 39 | 2 | 487 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.87e-03 | 43 | 39 | 2 | 409 | |
| Coexpression | LEE_CALORIE_RESTRICTION_MUSCLE_UP | 3.06e-06 | 43 | 61 | 4 | MM669 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 4.03e-06 | 46 | 61 | 4 | MM670 | |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 4.78e-06 | 48 | 61 | 4 | M1568 | |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 5.20e-06 | 49 | 61 | 4 | MM1178 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_B_CELL_AGEING | 1.63e-05 | 231 | 61 | 6 | MM3741 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP | 1.01e-04 | 199 | 61 | 5 | M4846 | |
| Coexpression | GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP | 1.03e-04 | 200 | 61 | 5 | M9771 | |
| Coexpression | RAMALHO_STEMNESS_UP | 1.11e-04 | 203 | 61 | 5 | MM1017 | |
| Coexpression | SHEPARD_CRASH_AND_BURN_MUTANT_UP | 1.16e-04 | 205 | 61 | 5 | M10828 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_8HR | 1.29e-04 | 42 | 61 | 3 | MM691 | |
| Coexpression | VANASSE_BCL2_TARGETS_UP | 1.39e-04 | 43 | 61 | 3 | MM799 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.37e-05 | 204 | 60 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_100 | 5.32e-05 | 26 | 60 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_100 | 6.68e-05 | 28 | 60 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_B_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#4_top-relative-expression-ranked_200 | 9.11e-05 | 31 | 60 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_500 | 1.03e-04 | 86 | 60 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_500_k1 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.58e-07 | 200 | 62 | 6 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.94e-06 | 178 | 62 | 5 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | 7.89e-06 | 196 | 62 | 5 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e | |
| ToppCell | (5)_Fibroblast-K_(Pericytes)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.89e-06 | 196 | 62 | 5 | e3c89c5bd674289738d5590ebfd30c605f5156a5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-06 | 196 | 62 | 5 | 70b2e0b4ff4f1bc03fb72ace07a8a44f4b415922 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-06 | 196 | 62 | 5 | ac4c8571bd792538f8df7b9bdd90ef58405fd3b1 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.28e-06 | 198 | 62 | 5 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.49e-06 | 199 | 62 | 5 | 534dcfe8b65ad92bb8d749d1c7036ad4807e09cd | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.31e-05 | 154 | 62 | 4 | ec920cae12ea1d14b6c973f6e903f895f80e3c50 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.50e-05 | 161 | 62 | 4 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.84e-05 | 168 | 62 | 4 | 8459d0a1bf6d4b5c83001097331f8b78fceb9305 | |
| ToppCell | Pericytes-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 9.46e-05 | 171 | 62 | 4 | bbc8d9fc83d37c9250345b1e76776610799de9ae | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.03e-04 | 175 | 62 | 4 | fed9e4120c758fdcc23bb248d1801002b0e0d485 | |
| ToppCell | Pericytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-04 | 175 | 62 | 4 | ddf721023a7afc8085c5de17aa254a6575444c0f | |
| ToppCell | COPD-Stromal-SMC|World / Disease state, Lineage and Cell class | 1.13e-04 | 179 | 62 | 4 | b2709537ec1b46457ab85261f4cdd354e60a8b29 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.18e-04 | 181 | 62 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 182 | 62 | 4 | 37547b36264090b49a193a8ef3a8d88e647f0b79 | |
| ToppCell | Pericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.23e-04 | 183 | 62 | 4 | d04deef7cd4e1738227a6593b84874ce0168c773 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.25e-04 | 184 | 62 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 185 | 62 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 186 | 62 | 4 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 186 | 62 | 4 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 186 | 62 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.31e-04 | 186 | 62 | 4 | c7885fd6dc7dc8fffc96f0112c51a365cf8a8f80 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.34e-04 | 187 | 62 | 4 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 1.36e-04 | 188 | 62 | 4 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 1.36e-04 | 188 | 62 | 4 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 191 | 62 | 4 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 191 | 62 | 4 | 2a107e9096eb58b81b3da61547904d85754f6b2f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 191 | 62 | 4 | d35692c652977500a3c36aa26c347a072b71e441 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-04 | 193 | 62 | 4 | 4aa976b596830b585e8d9c808d5072ed23d13a7c | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.51e-04 | 193 | 62 | 4 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 193 | 62 | 4 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-04 | 193 | 62 | 4 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.51e-04 | 193 | 62 | 4 | 4e78ddc96d8e403a21c4a303b1f26512d2ac91e8 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 194 | 62 | 4 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 195 | 62 | 4 | 26a3a5daf389606ef1ebb35533f12e60853b3a12 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.60e-04 | 196 | 62 | 4 | b10810c6a2ad3d3b968bfef46a68a38e0ce31331 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.60e-04 | 196 | 62 | 4 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 196 | 62 | 4 | 208ddedd29e1b9ca89cbb9b527c2e193a44cada2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 196 | 62 | 4 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.60e-04 | 196 | 62 | 4 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.63e-04 | 197 | 62 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 197 | 62 | 4 | d16bb765afdc02406ffd7ce6a75bae72b66db66c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 197 | 62 | 4 | 78d45d11820ec379942c4c3defd619d5f8cc8e1f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 197 | 62 | 4 | 31bc9fd679d78550541d4158568e8dd09ff29e8e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 197 | 62 | 4 | b7e399b8e1a1ffc2b359f14929f199b93d9bbcce | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 198 | 62 | 4 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 198 | 62 | 4 | c82a151f9f1477d4a401457173b8d72af776c137 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.66e-04 | 198 | 62 | 4 | dc63b56bb6291e527b172d603569376286262845 | |
| ToppCell | Caecum-T_cell-Tfh|Caecum / Region, Cell class and subclass | 1.69e-04 | 199 | 62 | 4 | fb40f37d842f170ed101dfa3bffdb8f3b2c94f19 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.69e-04 | 199 | 62 | 4 | c8bc05dece8b8a87d4a7a3e8112b924e15217de1 | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.69e-04 | 199 | 62 | 4 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.69e-04 | 199 | 62 | 4 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Caecum-(1)_T_cell-(16)_Tfh|Caecum / shred on region, Cell_type, and subtype | 1.69e-04 | 199 | 62 | 4 | d07d77ae426dd1164d80d7031f14befa0369d3e5 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 199 | 62 | 4 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.69e-04 | 199 | 62 | 4 | 3003badee037d4d63a8018a74c0aea213d049e43 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 199 | 62 | 4 | 8ff0fdcbe9661b013913731ec8b53d84836ca865 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.69e-04 | 199 | 62 | 4 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-04 | 199 | 62 | 4 | 78b245d40c1e169ff2d26907b63d732e34529c5f | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-04 | 199 | 62 | 4 | 8e1e95c3a4b856415af208be6ad977e575bac189 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-04 | 200 | 62 | 4 | 2bc7f462a551292de2501028164573935232f899 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | proximal-3-mesenchymal-Airway_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.73e-04 | 200 | 62 | 4 | e9a008bfe336002218c63d1c2231986e1b237621 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.73e-04 | 200 | 62 | 4 | c968d077b7fd24fb06cedb51c737996f25667eb7 | |
| ToppCell | proximal-mesenchymal-Airway_Smooth_Muscle|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.73e-04 | 200 | 62 | 4 | 5eeb8eb3fe74f5a8055c52ec77e38237bb63ed90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | proximal-mesenchymal-Airway_Smooth_Muscle-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.73e-04 | 200 | 62 | 4 | 6fa339666c4032b29ac521e88f0e917a57013cde | |
| ToppCell | distal-3-mesenchymal-Airway_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.73e-04 | 200 | 62 | 4 | 4072cfb3047954f507289587b4bfaf1526936992 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-04 | 200 | 62 | 4 | 8b80a65b69b36ed405214564b939452c90aa40d6 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 5.30e-07 | 190 | 58 | 7 | 1612_DN | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; HL60; HT_HG-U133A | 1.05e-05 | 196 | 58 | 6 | 2441_DN | |
| Drug | Nsc687160 | 1.25e-05 | 18 | 58 | 3 | CID005459290 | |
| Drug | tolytoxin | 1.48e-05 | 19 | 58 | 3 | CID006440827 | |
| Drug | m2-19 | 1.48e-05 | 19 | 58 | 3 | CID000079129 | |
| Drug | AC1L8NVR | 2.02e-05 | 21 | 58 | 3 | CID000384633 | |
| Drug | NSC312786 | 2.02e-05 | 21 | 58 | 3 | CID000329495 | |
| Drug | AC1L1ERT | 2.90e-05 | 69 | 58 | 4 | CID000002920 | |
| Drug | CID5288653 | 4.91e-05 | 28 | 58 | 3 | CID005288653 | |
| Drug | azaspiracid | 6.07e-05 | 30 | 58 | 3 | CID006451158 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 6.89e-05 | 86 | 58 | 4 | CID000000805 | |
| Drug | AC1L1HS4 | 7.38e-05 | 32 | 58 | 3 | CID000004267 | |
| Drug | AC1L1BDQ | 7.91e-05 | 173 | 58 | 5 | CID000001394 | |
| Drug | N,N'-p-phenylenedimaleimide | 8.88e-05 | 34 | 58 | 3 | CID000076765 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 8.88e-05 | 34 | 58 | 3 | CID000001312 | |
| Drug | Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 9.79e-05 | 181 | 58 | 5 | 2403_DN | |
| Drug | AC1NSKFN | 1.06e-04 | 36 | 58 | 3 | CID005311324 | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A | 1.29e-04 | 192 | 58 | 5 | 1365_DN | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Down 200; 10.4uM; HL60; HT_HG-U133A | 1.29e-04 | 192 | 58 | 5 | 2378_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 1160_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 3864_DN | |
| Drug | etheno-NAD | 1.44e-04 | 104 | 58 | 4 | CID005288160 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 2375_DN | |
| Drug | Estrone [53-16-7]; Down 200; 14.8uM; HL60; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 3071_DN | |
| Drug | epsilon-ATP | 1.56e-04 | 41 | 58 | 3 | CID000162262 | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; HL60; HT_HG-U133A | 1.56e-04 | 200 | 58 | 5 | 2167_UP | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.56e-04 | 200 | 58 | 5 | 2912_UP | |
| Drug | AC1OAGGW | 1.67e-04 | 203 | 58 | 5 | CID006857364 | |
| Disease | Intellectual Disability | 1.56e-07 | 447 | 56 | 9 | C3714756 | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 3.60e-07 | 8 | 56 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 3.60e-07 | 8 | 56 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 3.60e-07 | 8 | 56 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 3.60e-07 | 8 | 56 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 7.70e-07 | 10 | 56 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 7.70e-07 | 10 | 56 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 3.00e-05 | 93 | 56 | 4 | C1535926 | |
| Disease | white matter volume measurement | 3.09e-05 | 32 | 56 | 3 | EFO_0008320 | |
| Disease | femoral neck bone geometry | 3.17e-04 | 14 | 56 | 2 | EFO_0004511 | |
| Disease | Attention deficit hyperactivity disorder | 9.51e-04 | 24 | 56 | 2 | C1263846 | |
| Disease | neutrophil count | 1.10e-03 | 1382 | 56 | 9 | EFO_0004833 | |
| Disease | caudate nucleus volume | 1.49e-03 | 30 | 56 | 2 | EFO_0004830 | |
| Disease | apolipoprotein B measurement | 1.57e-03 | 663 | 56 | 6 | EFO_0004615 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DELGQQSMEDSEEDC | 1261 | Q9P281 | |
| MCDEDETTALVCDNG | 1 | P68133 | |
| EEGTVLMEDSDGNCE | 881 | Q01954 | |
| MCEEEDSTALVCDNG | 1 | P62736 | |
| EDVGVICSDASDMEL | 676 | Q9NR16 | |
| SDIETAADKCEEMEE | 986 | Q96KQ4 | |
| LVCESELDGTDMAEA | 96 | Q9C0F0 | |
| VVEECAADTDMEDGS | 1146 | Q8IZY2 | |
| MADVEDGEETCALAS | 1 | Q9UBF6 | |
| LCSTDQEEEEEMIFG | 16 | Q9UKA8 | |
| FTCVDDADVDSEMDP | 156 | Q96L73 | |
| SSAMDCEDDEVLDSE | 161 | Q9UM07 | |
| AAAEISMGTEVSEED | 236 | Q9Y2X3 | |
| EEVENVADIGFDCSM | 1121 | Q8NEZ4 | |
| DGSDEMDCVTECKED | 3621 | Q9NZR2 | |
| EMETESDAEVECDLS | 121 | Q9NWZ8 | |
| HSTMGDDEDACSDTE | 76 | Q96PQ5 | |
| DDEDACSDTETTEAM | 81 | Q96PQ5 | |
| ETEENIEGEMSSEDC | 306 | Q2LD37 | |
| FMASEEGTNCIDVDE | 946 | Q14766 | |
| MGDEDDDESCAVELR | 1 | O75676 | |
| AADSCAIMEGEDNEE | 976 | A8MWY0 | |
| DDEDACSDTEATEAM | 81 | P41236 | |
| ADEACAPDTESNMAE | 116 | P49619 | |
| SDDAESDVRMVADEC | 136 | P42858 | |
| IDLEDDDVVAMTSDC | 96 | Q9P109 | |
| EDEVSCEEDLVVGEM | 751 | Q14CM0 | |
| SASMEEEGEDCTLSV | 1021 | Q86V48 | |
| VCDEEMDLAIEASEA | 286 | Q14974 | |
| DGQMDDLVCFEELTD | 41 | Q9GZR7 | |
| EDADMLESEECEASK | 466 | Q8NA03 | |
| CSDDELMTEGEDQFD | 381 | P16298 | |
| VSLGSMDDEEFAEVD | 901 | Q03701 | |
| GDTEEEVFDCIVNMD | 761 | Q6P5Z2 | |
| AETSCDTMQGAEEEE | 596 | Q5JY77 | |
| ATCESGAGSEVEVDM | 841 | Q5VVP1 | |
| DIEDTEQANEDTMEC | 426 | Q9NVN8 | |
| TCESGAGSEVEVDMF | 846 | Q8IWB4 | |
| EECEEEESESFADMM | 91 | Q96PZ0 | |
| MVCEAADDAPSSEEE | 2241 | O60287 | |
| MCDDEETTALVCDNG | 1 | P68032 | |
| MVICEEEGDDDVIAD | 441 | Q96RK0 | |
| TCESGAGSEVEVDMF | 846 | Q5VYP0 | |
| MGNDISAEDICAEDI | 456 | O95625 | |
| GSRNSCEGEDEEEME | 651 | Q13107 | |
| MEICATDAVDDMEEG | 326 | Q2NL82 | |
| CDIIDSSDEMDAQEE | 91 | Q8IXX5 | |
| TCESGAGSEVEVDMF | 846 | Q5TZJ5 | |
| TCESGAGSEVEVDMF | 846 | Q5VU36 | |
| DDEDACRDTETTEAM | 81 | Q6NXS1 | |
| DVCADMVGTFTDTED | 86 | P02753 | |
| MADEEAEQERLSCGE | 1 | O60281 | |
| GSATEDKDSMETDDC | 1256 | Q5SRE5 | |
| TTQMSDEEEDDDGCD | 246 | Q9Y4E1 | |
| DDDMEGDEAVVRCTL | 226 | O75643 | |
| TTQMSDEEEDDDGCD | 246 | Q641Q2 | |
| ASTDEQDAMDGELVC | 511 | Q9UIA9 | |
| TEGGDICMEEEEEHS | 1086 | Q9UL36 | |
| EEGSDDCSEMCDGEE | 386 | Q13342 | |
| DCSEMCDGEERQEAS | 391 | Q13342 | |
| CEDTEAMDDVVEQDA | 221 | Q969S3 | |
| VAMEASSDGEEDAES | 771 | Q5H9R7 | |
| ESSAELVAESMGEEC | 491 | P23378 | |
| DMVCESSVTDEDSDF | 146 | Q8N8K9 | |
| CTWGMGEDAVEDDAE | 336 | Q9BWU0 | |
| SVDECDDSDGTEDMD | 86 | Q9UL68 |